Literature DB >> 21682836

ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.

Angela Gallo1, Franco Locatelli.   

Abstract

Adenosine deaminases acting on RNA (ADARs) are enzymes that convert adenosine (A) to inosine (I) in nuclear-encoded RNAs and viral RNAs. The activity of ADARs has been demonstrated to be essential in mammals and serves to fine-tune different proteins and modulate many molecular pathways. Recent findings have shown that ADAR activity is altered in many pathological tissues. Moreover, it has been shown that modulation of RNA editing is important for cell proliferation and migration, and has a protective effect on ischaemic insults. This review summarises available recent knowledge on A-to-I RNA editing and ADAR enzymes, with particular attention given to the emerging role played by these enzymes in cancer, some infectious diseases and immune-mediated disorders.
© 2011 The Authors. Biological Reviews © 2011 Cambridge Philosophical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682836     DOI: 10.1111/j.1469-185X.2011.00186.x

Source DB:  PubMed          Journal:  Biol Rev Camb Philos Soc        ISSN: 0006-3231


  30 in total

1.  miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.

Authors:  Alessandro Laganà; Alessio Paone; Dario Veneziano; Luciano Cascione; Pierluigi Gasparini; Stefania Carasi; Francesco Russo; Giovanni Nigita; Valentina Macca; Rosalba Giugno; Alfredo Pulvirenti; Dennis Shasha; Alfredo Ferro; Carlo M Croce
Journal:  Bioinformatics       Date:  2012-10-07       Impact factor: 6.937

2.  A-to-I RNA editing independent of ADARs in filamentous fungi.

Authors:  Chenfang Wang; Jin-Rong Xu; Huiquan Liu
Journal:  RNA Biol       Date:  2016-08-17       Impact factor: 4.652

3.  REDIportal: a comprehensive database of A-to-I RNA editing events in humans.

Authors:  Ernesto Picardi; Anna Maria D'Erchia; Claudio Lo Giudice; Graziano Pesole
Journal:  Nucleic Acids Res       Date:  2016-09-01       Impact factor: 16.971

Review 4.  Gene regulation in the immune system by long noncoding RNAs.

Authors:  Y Grace Chen; Ansuman T Satpathy; Howard Y Chang
Journal:  Nat Immunol       Date:  2017-08-22       Impact factor: 25.606

Review 5.  When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.

Authors:  Yumeng Wang; Han Liang
Journal:  Bioessays       Date:  2017-12-27       Impact factor: 4.345

Review 6.  Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.

Authors:  Andrew J Fisher; Peter A Beal
Journal:  RNA Biol       Date:  2016-12-12       Impact factor: 4.652

7.  Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.

Authors:  Vasudevan Achuthan; Brian J Keith; Bernard A Connolly; Jeffrey J DeStefano
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

8.  Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.

Authors:  Cornelia Vesely; Stefanie Tauber; Fritz J Sedlazeck; Arndt von Haeseler; Michael F Jantsch
Journal:  Genome Res       Date:  2012-02-06       Impact factor: 9.043

9.  Genome-wide analysis of Alu editability.

Authors:  Lily Bazak; Erez Y Levanon; Eli Eisenberg
Journal:  Nucleic Acids Res       Date:  2014-05-14       Impact factor: 16.971

10.  ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.

Authors:  Sara Tomaselli; Federica Galeano; Luca Massimi; Concezio Di Rocco; Libero Lauriola; Angela Mastronuzzi; Franco Locatelli; Angela Gallo
Journal:  BMC Cancer       Date:  2013-05-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.